Predicting relapse in patients submitted to postoperative concurrent chemoradiation for high-risk head and neck squamous cell carcinoma (2004)
- Authors:
- USP affiliated authors: FEDERICO, MIRIAM HATSUE HONDA - FM ; NADALIN, WLADIMIR - FM ; FERRAZ, ALBERTO ROSSETTI - FM
- Unidade: FM
- Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO (QUIMIOTERAPIA); CARCINOMA DE CÉLULAS ESCAMOSAS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Annals of Oncology
- ISSN: 0923-7534
- Volume/Número/Paginação/Ano: v. 15, suppl. 3, p. iii144, res. 541P, 2004
- Conference titles: Abstract Boof of the ESMO Congress
-
ABNT
CASTRO JUNIOR, Gilberto et al. Predicting relapse in patients submitted to postoperative concurrent chemoradiation for high-risk head and neck squamous cell carcinoma. Annals of Oncology. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 17 abr. 2024. , 2004 -
APA
Castro Junior, G., Siqueira, S. A., Snitcovsky, I. M., Leitão, G. M., Nadalin, W., Ferraz, A. R., & Federico, M. H. H. (2004). Predicting relapse in patients submitted to postoperative concurrent chemoradiation for high-risk head and neck squamous cell carcinoma. Annals of Oncology. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Castro Junior G, Siqueira SA, Snitcovsky IM, Leitão GM, Nadalin W, Ferraz AR, Federico MHH. Predicting relapse in patients submitted to postoperative concurrent chemoradiation for high-risk head and neck squamous cell carcinoma. Annals of Oncology. 2004 ; 15 iii144.[citado 2024 abr. 17 ] -
Vancouver
Castro Junior G, Siqueira SA, Snitcovsky IM, Leitão GM, Nadalin W, Ferraz AR, Federico MHH. Predicting relapse in patients submitted to postoperative concurrent chemoradiation for high-risk head and neck squamous cell carcinoma. Annals of Oncology. 2004 ; 15 iii144.[citado 2024 abr. 17 ] - High-dose cisplatin concurrent to concentionally delivered radiotherapy is associated with unacceptable toxicity in unresectable, non-metastatic stage IV head and neck squamous cell carcinoma
- Quimiorradioterapia (QRT) concomitante em pacientes portadores de carcinoma espinocelular de cabeça e pescoço (CECCP) não elegiveis para tratamento cirurgico
- Efficacy and safety of concurrent chemoradiotherapy (CCR) for unresectable locally advanced (ULA) head and neck squamous cell carcinoma (HNSCC)
- Quimiorradioterapia concomitante (QRT) em pacientes portadoras de carcinoma epidermóide de cabeça e pescoço (CECCP) localmente avançado, não elegíveis para tratamento cirúrgico
- Patients (pts) with stage IV, non-metastatic advanced head and neck squamous cell carcinoma (HNSCC) submitted to concurrent chemoradiotherapy (CCR)
- Prognostic significance of clinical-pathological features in high-risk head and neck squamous cell carcinoma (HNSCC) patients (pts) treated with postoperative concurrent chemoradiation (CRT)
- High pathologic response rate of neoadjuvant chemoradiation with gemcitabine in locally advanced vulvar carcinoma
- Radioterapia associada a gencitabina no tratamento neoadjuvante do carcinoma vulvar
- ERCC1 protein, mRNA expression, and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma (HNSCC) patients treated with surgery and adjuvant cisplatin-based chemoradiation (CRT)
- ERCC1 protein, mRNA expression and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma patients treated with surgery and adjuvant cisplatin-based chemoradiation
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas